Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    "Brittle cornea syndrome"
Show Display Options
Rank Status Study
1 Enrolling by invitation Riboflavin Corneal Crosslinking for Brittle Cornea Syndrome and Ehlers-Danlos Syndrome Type VI
Conditions: Brittle Cornea Syndrome;   Ehlers-Danlos Syndrome Type 6
Interventions: Drug: Riboflavin;   Device: Kera-X

Indicates status has not been verified in more than two years